2025年生技藥品檢測全球市場報告

預計未來幾年生技藥品檢測市場將快速成長，到2029年將達到128.4億美元，複合年成長率為17.1%。預測期內的成長動力包括先進療法的湧現、合約檢測服務需求的不斷成長、生技藥品產品線的不斷拓展、生物製藥生產的全球化以及快速檢測解決方案需求的不斷成長。預測期內的主要趨勢包括先進的分析技術、細胞化驗分析、次世代定序(NGS)、品質源自於設計 (QBD) 原則、人工智慧 (AI) 的整合以及加速的產品發布方法。

未來五年17.1%的成長率預測比我們先前的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。關稅上調可能會增加美國製藥商的負擔，使其從英國和荷蘭採購的免疫抗原性測試和表徵服務的成本增加，從而延長研發週期，並增加分析測試成本。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

預計快速發展的製藥和生物技術行業將在未來幾年顯著推動生技藥品檢測市場的成長。製藥業主要專注於開發和生產針對各種疾病和醫療狀況的藥物，而生物技術產業則專注於技術在生物學和醫療保健領域的應用。生技藥品檢測包括旨在識別和量化雜質、評估藥物穩定性以及評估藥物免疫反應的測試。這些產業的成長也推動了生技藥品檢測技術的進步，包括開發新的分析工具和技術。這些技術創新促進了更準確、更有效率的檢測流程，從而減少了將新生技藥品推向市場所需的時間和成本。例如，比利時管理機構歐盟統計局的報告預測，歐盟藥品產值將從2021年的360億歐元（約394億美元）成長到2023年的440億歐元（約467億美元），這顯示該產業將實現顯著成長。因此，製藥和生物技術行業的快速擴張正在推動生技藥品檢測市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球生技藥品測試：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球生技藥品檢測市場：成長率分析
• 全球生技藥品檢測市場表現：規模與成長，2019-2024
• 全球生技藥品檢測市場預測：規模與成長，2024-2029年，2034年
• 全球生技藥品測試：總目標市場（TAM）

第6章 市場細分

• 全球生技藥品檢測市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 試劑和套件
• 裝置
• 其他產品
• 全球生技藥品檢測市場（按檢測類型、實際情況和預測），2019-2024 年、2024-2029 年、2034 年
• 內毒素檢測
• 無菌測試
• 黴漿菌檢測
• 微生物附著量測試
• 殘留宿主細胞蛋白質和DNA檢測試驗
• 病毒安全測試
• 其他測試類型
• 全球生技藥品檢測市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 疫苗研發與生產
• 單株抗體開發與生產
• 細胞和基因治療產品開發和製造
• 血液及血液製品的開發與生產
• 其他用途
• 全球生技藥品檢測市場：按試劑和套件（按類型）細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
• ELISA套件
• PCR套件
• 細胞培養試劑
• 其他檢測試劑套件
• 全球生技藥品檢測市場：依儀器類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 光強度
• 層析法系統
• 微孔盤讀數儀
• 其他分析儀器
• 全球生技藥品檢測市場：依產品類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 軟體
• 耗材
• 參考標準

第7章 區域和國家分析

• 全球生技藥品檢測市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
• 全球生技藥品檢測市場：依國家分類、實際及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 生技藥品檢測市場：競爭格局
• 生技藥品檢測市場：公司簡介
  • Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • SGS Societe Generale de Surveillance SA Overview, Products and Services, Strategy and Financial Analysis
  • WuXi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Sartorius AG
• Cytovance Biologics Inc.
• Pace Analytical Services Inc.
• Avance Biosciences Inc.
• Celgene Corporation
• Biomerieux SA
• Lonza Group Ltd.
• Genscript Biotech Corp.
• Bio-Rad Laboratories Inc.
• Accugen Laboratories Inc.
• Gibraltar Laboratories Inc.
• Jordi Labs
• Gilead Sciences Inc.
• Bioquell Limited
• Southern Research

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029 年生技藥品檢測市場：提供新機會的國家
• 2029 年生技藥品檢測市場：細分領域帶來新機會
• 2029年生技藥品檢測市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Biologics testing encompasses a spectrum of services designed to assess the safety, effectiveness, and quality of biological products.

Within the realm of biologics testing, the primary products include reagents, kits, instruments, and other related items. Instruments, in this context, refer to tools, devices, or machines utilized for conducting experiments, analyzing data, or observing biological samples. The suite of tests involved in biologics testing spans various assessments such as endotoxin testing, sterility testing, mycoplasma testing, bioburden testing, residual detection of host-cell proteins and DNA, virus safety testing, and other specialized tests. These tests find applications across vaccine development and manufacturing, the development and manufacturing of monoclonal antibodies, cellular and gene therapy products, blood and blood products, and various other applications within the biologics industry.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biologics testing market research report is one of a series of new reports from The Business Research Company that provides biologics testing optical components market statistics, including biologics testing optical components industry global market size, regional shares, competitors with a biologics testing optical components market share, detailed biologics testing optical components market segments, market trends and opportunities, and any further data you may need to thrive in the biologics testing optical components industry. This biologics testing optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biologics testing market size has grown rapidly in recent years. It will grow from $5.92 billion in 2024 to $6.83 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to growth in biologics development, stringent regulatory standards, quality control in bioprocessing, rise in biopharmaceutical investments, expansion of biomanufacturing capacity.

The biologics testing market size is expected to see rapid growth in the next few years. It will grow to $12.84 billion in 2029 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to emergence of advanced therapies, increasing demand for contract testing services, expansion of biologics pipelines, globalization of biopharmaceutical manufacturing, increasing demand for rapid testing solutions. Major trends in the forecast period include advanced analytical technologies, cell-based assays, next-generation sequencing (NGS), quality by design (QBD) principles, integration of artificial intelligence (AI), rapid methods for product release.

The forecast of 17.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. drug manufacturers by driving up the cost of immunogenicity assays and characterization services sourced from the UK and Netherlands, exacerbating development timelines and increasing analytical testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The swiftly expanding pharmaceutical and biotechnology sectors are expected to significantly boost the growth of the biologics testing market in the future. The pharmaceutical industry mainly focuses on the development and production of medications for a variety of diseases and medical conditions, while the biotechnology sector emphasizes the application of technology in biology and healthcare. Biologics testing encompasses tests designed to identify and quantify impurities, assess drug stability, and evaluate immune responses to medications. The growth of these industries has also spurred advancements in biologics testing technologies, including the creation of new analytical tools and techniques. These innovations have facilitated more accurate and efficient testing processes, thereby reducing the time and cost associated with bringing new biologics to market. For example, a report from Eurostat, a Belgium-based governing body, revealed that pharmaceutical production in the EU rose from €36 billion ($39.4 billion) in 2021 to €44 billion ($46.7 billion) in 2023, indicating substantial growth in the sector. Consequently, the rapid expansion of the pharmaceutical and biotechnology industries is driving the growth of the biologics testing market.

The projected growth of the biologics testing market is further fueled by rising government initiatives in research and development, a pivotal catalyst for advancing safety, effectiveness, and innovation in biologics. Government initiatives encompass various facets of biologics testing, ensuring safety and efficacy through robust support programs. The White House's substantial funding allocation of $204.9 billion for research and development in the President's 2023 budget reflects this commitment, representing a 28% increase from the 2021 level. These initiatives significantly contribute to the growth of the biologics testing market by nurturing innovation and advancing research.

A prominent trend in the biologics testing market is the focus on product innovations, with companies striving to introduce cutting-edge solutions to maintain their market positions. Noteworthy is Charles River Laboratories International, Inc.'s December 2022 launch of the Endosafe Nexus 200TM, a state-of-the-art instrument in their endotoxin testing line. This instrument, utilizing Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology, streamlines processes for water, in-process, and final product testing, offering enhanced traceability, security, and data management.

Major companies in the biologics testing market are innovating with new technologies, such as protein engineering techniques, to enhance profitability. Queensland University of Technology's launch of a novel protein-engineering technique in July 2023 underscores this trend. This groundbreaking technology aims to expedite and refine the creation of diagnostic tests, promising significant positive impacts on both healthcare and the economy. Such innovations are instrumental in driving advancements within the biologics testing market, fostering growth and profitability.

In July 2022, Solvias Inc., a pharmaceutical testing and manufacturing firm based in the U.S., acquired Cergentis B.V. for an undisclosed sum. This acquisition is intended to strengthen Solvias's capabilities in biologics and cell and gene therapy (CGT) testing solutions, addressing the increasing demand in these areas. Cergentis B.V., located in the Netherlands, is a biotechnology company that specializes in offering innovative solutions in genomics and molecular biology.

Major companies operating in the biologics testing market include Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Societe Generale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Celgene Corporation, Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Gilead Sciences Inc., Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, Johnson & Johnson Inc., QIAGEN N.V., GlaxoSmithKline plc, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG, Novartis AG, Eli Lilly and Company, Pfizer Inc.

North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biologics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biologics testing market includes revenues earned by entities by providing services such as potency testing, purity testing, sterility testing, immunogenicity testing and others. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologics Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biologics testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Kits; Instruments; Other Products
• 2) By Test Type: Endotoxin Test; Sterility Test; Mycoplasma Tests; Bioburden Tests; Residual Host-Cell Proteins And DNA Detection Tests; Virus Safety Test; Other Test Types
• 3) By Application: Vaccine Development And Manufacturing; Monoclonal Antibodies Development And Manufacturing; Cellular And Gene Therapy Products Development And Manufacturing; Blood And Blood Products Development And Manufacturing; Other Applications
• Subsegments:
• 1) By Reagents And Kits: ELISA Kits; PCR Kits; Cell Culture Reagents; Other Assay Kits
• 2) By Instruments: Spectrophotometers; Chromatography Systems; Microplate Readers; Other Analytical Instruments
• 3) By Other Products: Software; Consumables; Reference Standards
• Companies Mentioned: Charles River Laboratories Inc.; Thermo Fisher Scientific Inc.; Merck KGaA; SGS Societe Generale de Surveillance SA; WuXi AppTec Co. Ltd.; Sartorius AG; Cytovance Biologics Inc.; Pace Analytical Services Inc.; Avance Biosciences Inc.; Celgene Corporation; Biomerieux SA; Lonza Group Ltd.; Genscript Biotech Corp.; Bio-Rad Laboratories Inc.; Accugen Laboratories Inc.; Gibraltar Laboratories Inc.; Jordi Labs; Gilead Sciences Inc.; Bioquell Limited; Southern Research; Promega Corporation; Lancaster Laboratories Inc.; Toxikon Corporation; Eurofins BioPharma Product Testing; Johnson & Johnson Inc.; QIAGEN N.V.; GlaxoSmithKline plc; Danaher Corporation; Agilent Technologies Inc.; PerkinElmer Inc.; Abbott Laboratories; Beckman Coulter Inc.; Becton Dickinson and Company; Roche Holding AG; Novartis AG; Eli Lilly and Company; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologics Testing Market Characteristics

3. Biologics Testing Market Trends And Strategies

4. Biologics Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biologics Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biologics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biologics Testing Market Growth Rate Analysis
• 5.4. Global Biologics Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biologics Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biologics Testing Total Addressable Market (TAM)

6. Biologics Testing Market Segmentation

• 6.1. Global Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Instruments
• Other Products
• 6.2. Global Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endotoxin Test
• Sterility Test
• Mycoplasma Tests
• Bioburden Tests
• Residual Host-Cell Proteins And DNA Detection Tests
• Virus Safety Test
• Other Test Types
• 6.3. Global Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccine Development And Manufacturing
• Monoclonal Antibodies Development And Manufacturing
• Cellular And Gene Therapy Products Development And Manufacturing
• Blood And Blood Products Development And Manufacturing
• Other Applications
• 6.4. Global Biologics Testing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA Kits
• PCR Kits
• Cell Culture Reagents
• Other Assay Kits
• 6.5. Global Biologics Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spectrophotometers
• Chromatography Systems
• Microplate Readers
• Other Analytical Instruments
• 6.6. Global Biologics Testing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Consumables
• Reference Standards

7. Biologics Testing Market Regional And Country Analysis

• 7.1. Global Biologics Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biologics Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biologics Testing Market

• 8.1. Asia-Pacific Biologics Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biologics Testing Market

• 9.1. China Biologics Testing Market Overview
• 9.2. China Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biologics Testing Market

• 10.1. India Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biologics Testing Market

• 11.1. Japan Biologics Testing Market Overview
• 11.2. Japan Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biologics Testing Market

• 12.1. Australia Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biologics Testing Market

• 13.1. Indonesia Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biologics Testing Market

• 14.1. South Korea Biologics Testing Market Overview
• 14.2. South Korea Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biologics Testing Market

• 15.1. Western Europe Biologics Testing Market Overview
• 15.2. Western Europe Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biologics Testing Market

• 16.1. UK Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biologics Testing Market

• 17.1. Germany Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biologics Testing Market

• 18.1. France Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biologics Testing Market

• 19.1. Italy Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biologics Testing Market

• 20.1. Spain Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biologics Testing Market

• 21.1. Eastern Europe Biologics Testing Market Overview
• 21.2. Eastern Europe Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biologics Testing Market

• 22.1. Russia Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biologics Testing Market

• 23.1. North America Biologics Testing Market Overview
• 23.2. North America Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biologics Testing Market

• 24.1. USA Biologics Testing Market Overview
• 24.2. USA Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biologics Testing Market

• 25.1. Canada Biologics Testing Market Overview
• 25.2. Canada Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biologics Testing Market

• 26.1. South America Biologics Testing Market Overview
• 26.2. South America Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biologics Testing Market

• 27.1. Brazil Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biologics Testing Market

• 28.1. Middle East Biologics Testing Market Overview
• 28.2. Middle East Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biologics Testing Market

• 29.1. Africa Biologics Testing Market Overview
• 29.2. Africa Biologics Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biologics Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biologics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biologics Testing Market Competitive Landscape And Company Profiles

• 30.1. Biologics Testing Market Competitive Landscape
• 30.2. Biologics Testing Market Company Profiles
  • 30.2.1. Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. SGS Societe Generale de Surveillance SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. WuXi AppTec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Biologics Testing Market Other Major And Innovative Companies

• 31.1. Sartorius AG
• 31.2. Cytovance Biologics Inc.
• 31.3. Pace Analytical Services Inc.
• 31.4. Avance Biosciences Inc.
• 31.5. Celgene Corporation
• 31.6. Biomerieux SA
• 31.7. Lonza Group Ltd.
• 31.8. Genscript Biotech Corp.
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. Accugen Laboratories Inc.
• 31.11. Gibraltar Laboratories Inc.
• 31.12. Jordi Labs
• 31.13. Gilead Sciences Inc.
• 31.14. Bioquell Limited
• 31.15. Southern Research

32. Global Biologics Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologics Testing Market

34. Recent Developments In The Biologics Testing Market

35. Biologics Testing Market High Potential Countries, Segments and Strategies

• 35.1 Biologics Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biologics Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biologics Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer